Insider Trading May 29, 2026 09:40 PM

Infleqtion Director Sells $47.6 Million in Shares Amid Quantum Computing Developments

Director David Singer divests significant stake through fund distributions, while the company reports Q1 revenue growth and secures potential Department of Commerce funding.

By Priya Menon INFQ

David B. Singer, a director at Infleqtion, Inc., recently sold approximately $47.6 million worth of common stock. These transactions involved the disposal of 3,071,623 shares. The sales were conducted through fund structures and occurred as the company reported positive revenue growth for Q1 2026, driven by quantum solutions, alongside securing potential funding from the U.S. Department of Commerce.

Infleqtion Director Sells $47.6 Million in Shares Amid Quantum Computing Developments
INFQ

Key Points

  • The sale activity by David B. Singer involved disposing of 3,071,623 shares worth approximately $47.6 million through structured fund distributions.
  • Infleqtion reported a 14% year-over-year increase in Q1 2026 revenue to $9.5 million, driven solely by quantum solutions.
  • The company confirmed maintaining a strong cash position of $569 million and zero debt, while also securing a Letter of Intent for potential $100 million funding from the U.S. Department of Commerce.

A review of recent filings with the Securities and Exchange Commission reveals that David B. Singer, a director at Infleqtion, Inc. (NASDAQ:INFQ), disposed of a substantial amount of common stock. Specifically, Mr. Singer sold common stock totaling approximately $47.6 million on May 27, 2026. The total transaction encompassed the sale of 3,071,623 shares of common stock.

The sales were channeled indirectly through two specific investment vehicles: Maverick Advisors Fund, L.P., and Maverick Ventures Investment Fund, L.P. These transactions constituted pro rata distributions, with the resulting proceeds being distributed to certain limited partners associated with these respective funds. Analysis of the sale pricing indicated that the weighted average prices ranged between $15.2879 and $15.9754 per share. More granular detail shows that some shares transacted at prices falling between $14.67 and $15.66, while other portions were sold at rates ranging from $15.67 to $16.38.

It is important to note the current market context for INFQ shares; the stock currently trades at $16.22, representing a notable 59% gain over the past year despite periods of fluctuation in its trading history.


Beyond the reported sales, the SEC filing also detailed several distributions and acquisitions of common stock that occurred on the same date but involved no consideration for the receiving parties. Maverick Advisors Fund distributed 460,072 shares to its limited partners. Similarly, Maverick Ventures Investment Fund distributed 508,549 shares to its limited partners. Furthermore, Mr. Singer personally received 349,693 shares through Maverick Ventures, and family estate planning entities controlled by him acquired an additional 83,773 shares. All these transfers were structured as part of pro rata distributions without requiring payment.


In parallel developments concerning the company's operational standing, Infleqtion provided data for its first quarter of 2026, reporting a year-over-year increase in revenue. This revenue reached $9.5 million, marking a 14% growth rate. The source of this positive financial movement was entirely attributed to the quantum solutions developed by the company.

However, the Q1 results also highlighted significant operational challenges. The company reported an operating loss amounting to $33.6 million. This substantial loss was primarily driven by two factors: stock-based compensation and various expenses associated with its go-public transaction. Despite these financial headwinds, Infleqtion maintains a robust financial footing. The company possesses a strong cash position of $569 million and reports having no outstanding debt.


The strategic outlook for the firm remains focused on advancing quantum computing capabilities. Notably, Infleqtion announced that it signed a Letter of Intent with the U.S. Department of Commerce’s CHIPS Research and Development Office. This agreement proposes $100 million in potential funding intended to advance quantum computing technologies. The realization of this funding is contingent upon meeting predefined development milestones and successfully completing due diligence procedures.

In addition to the proposed government support, the company also communicated advancements related to its neutral-atom quantum computing technology. As part of these updates, Infleqtion released an open-source resource estimation tool developed in collaboration with the University of Chicago. These various developments underscore the firm's continuous and dedicated efforts to enhance its overall quantum computing portfolio.


Risks

  • The reported operating loss of $33.6 million in Q1 2026, attributed to stock-based compensation and go-public transaction expenses, presents a short-term financial risk.
  • The potential $100 million funding from the U.S. Department of Commerce is explicitly stated as being contingent upon meeting specific development milestones and completing due diligence.

More from Insider Trading

Rackspace Technology Executive Offloads Shares to Cover Tax Obligations Amid Stock Surge Jun 4, 2026 Fermi Inc. Executive Unloads $1M in Shares Amid Ongoing Corporate Restructuring Jun 4, 2026 Veracyte Executive Sells Nearly $700K in Shares Amid Product Rollouts and Analyst Upgrades Jun 4, 2026 Veracyte Executive Traces Share Disposition Amid Clinical Milestones and Valuation Scrutiny Jun 4, 2026 Veracyte CFO Executes $177K Stock Sale Amid Clinical Trial Updates and Analyst Revisions Jun 4, 2026